Skip to content

Transcutaneous Electrical Spinal Cord Stimulation for Lower Limbs

A Theranostic Tool to Assess and Enable Spared Spinal Motor Function After SCI

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01949285
Enrollment
10
Registered
2013-09-24
Start date
2015-06-30
Completion date
2016-12-31
Last updated
2017-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury

Keywords

Spinal cord injury, Paralysis, Rehabilitation, Assessment, Theranostics

Brief summary

This study is to determine if non-invasive electrical stimulation of the spinal cord can be used to: 1) assess spared function following a spinal cord injury; and 2) be use for rehabilitation.

Detailed description

This study is to determine if non-invasive electrical stimulation of the spinal cord can be used to: 1) assess spared function following a spinal cord injury; and 2) be use for rehabilitation. The investigators hypothesize that this type of stimulation can be used to locate and determine if any spinal (nerve) pathways or connections were spared following a spinal cord injury. We also hypothesize the same stimulation can help revive or recover function to muscles connected to these spared spinal (nerve) pathways in individuals who are clinically paralyzed. Our research has demonstrated that modifying the activation state of the spinal cord after an injury, or awakening the spinal cord, can benefit people with paralysis years after a spinal cord injury. This method and device have not yet been approved by the FDA for the treatment of paralysis and are under investigation. This study if successful will help provide further evidence that could be use to one day to gain FDA approval.

Interventions

A prototype device that non-invasively delivers electrical stimulation to the spinal cord will be used to assess and rehabilitate spared spinal cord function.

Sponsors

University of California, Los Angeles
CollaboratorOTHER
California Institute of Technology
CollaboratorOTHER
NeuroEnabling Technologies, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

SCI ASIA A, B, C * Spinal cord injury 1 or more years prior * Non progressive cervical or thoracic SCI * Half of key muscles below neurological level having a motor score of less than 2/5 * Ability to commit to home exercises and 16 week participation * Stable medical condition without cardiopulmonary disease or dysautonomia that would contraindicate participation in lower extremity rehabilitation or testing activities * Not dependent on ventilation support * No painful musculoskeletal dysfunction, unhealed fracture, pressure sore, or urinary tract infection that might interfere with lower extremity rehabilitation or testing activities * No clinically significant depression or ongoing drug abuse * Adequate social support network to be able to participate in weekly training and assessment sessions for the duration of the 16 week study period * No current anti-spasticity regimen * Must not have received botox injections in the prior six months * Be unable to use lower extremity for functional tasks

Exclusion criteria

* Pregnancy * No functional segmental reflexes below the lesion

Design outcomes

Primary

MeasureTime frameDescription
Improvement in sensorimotor function in the lower extremities10-12 weeksSubjects will be tested by several measures of sensory and motor function, as well as self assessments of spasticity, quality of life, and independence. These tests include: American Spinal Injury Association (ASIA) scoring system, Spinal Cord Independence Measure (SCIM), Ashworth Spasticity Scale, Penn Spasm Frequency, Visual Analog Scale (VAS) for Spasticity, Electromyographic (EMG) recordings, Joint angle (goniometer) measures, kinematic analysis.

Secondary

MeasureTime frameDescription
Ability to stand independently2-4 weeksSubjects will be evaluated on their core body function and ability to stand

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026